Axq Capital »

Belite Bio shares owned by Axq Capital

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Axq Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $378k 2.4k 159.44

More positions owned by Axq Capital

Boston Scientific Corporation (BSX)
Cleveland-cliffs (CLF)
Otis Worldwide Corp (OTIS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Blackrock (BLK)
Ford Motor Company (F)
TPG Com Cl A (TPG)
Dollar Tree (DLTR)
3M Company (MMM)
Antero Midstream Corp antero midstream (AM)
Rocket Cos Com Cl A (RKT)
TransDigm Group Incorporated (TDG)
Insulet Corporation (PODD)
Wec Energy Group (WEC)
Colgate-Palmolive Company (CL)

View all positions for Axq Capital

Top funds holding Belite Bio

Darwin Global Management
Paradigm Biocapital Advisors
UBS Group
Rtw Investments
Millennium Management
Holocene Advisors
Eventide Asset Management
Deerfield Management Company
Morgan Stanley
Marshall Wace
Perceptive Advisors
Patient Square Capital
Duquesne Family Office
Goldman Sachs Group
MPM Oncology Impact Management

View all funds holding Belite Bio